September 3, 2024 01:22 PM EDTUpdated 03:59 PM
Pharma
FDA+

Eu­ro­pean Com­mis­sion re­vokes Ocali­va's au­tho­riza­tion ahead of FDA ad­comm

Katherine Lewin

News Reporter

Ad­vanz Phar­ma on Tues­day said its liv­er dis­ease treat­ment Ocali­va suf­fered a set­back as the Eu­ro­pean Com­mis­sion re­voked its con­di­tion­al mar­ket­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

A service from the Financial Times